CYH: the cashflow

MyFinsight

For the quarter ending 2025-09-30.

Cash Flow Overview

No enough data to generate the overview

Unit: Million (M) dollars (except for numbers of shares and EPS)

Cash Flow	2025-09-30	2025-06-30
Net operating revenues	9,379	-
Salaries and benefits	4,056	-
Supplies	1,418	-
Contract labor	119	-
Medical specialist fees	479	-
Other segment items	2,194	-
Depreciation and amortization	317	-
Interest expense	651	-
Interest income	2	-
Impairment and (gain) loss on sale of businesses, net	-242	-
Loss (gain) from early extinguishment of debt	105	-
Equity in earnings of unconsolidated affiliates	9	-
Benefit from income taxes	-13	-
Net income (loss)	516	345
Depreciation and amortization	317	211
Deferred income taxes	-261	9
Stock-based compensation expense	7	7
Impairment and (gain) loss on sale of businesses, net	-242	-263
Gain from early extinguishment of debt	105	138
Other non-cash expenses, net	-134	-92
Patient accounts receivable	-75	26
Supplies, prepaid expenses and other current assets	-5	13
Accounts payable, accrued liabilities and income taxes	-86	46
Other	83	62
Net cash provided by operating activities	277	208
Acquisitions of facilities and other related businesses	1	0
Purchases of property and equipment	241	176
Proceeds from disposition of hospitals and other ancillary operations	1,012	1,013
Proceeds from sale of property and equipment	8	5
Purchases of available-for-sale debt securities and equity securities	107	72
Proceeds from sales of available-for-sale debt securities and equity securities	87	58
Purchases of investments in unconsolidated affiliates	0	0
Increase in other investments	53	42
Net cash provided by (used in) investing activities	705	786
Repurchase of restricted stock shares for payroll tax withholding requirements	2	2
Deferred financing costs and other debt-related costs	9	2
Proceeds from noncontrolling investors in joint ventures	2	1
Redemption of noncontrolling investments in joint ventures	2	-
Distributions to noncontrolling investors in joint ventures	120	96
Other borrowings	16	15
Issuance of long-term debt	2,470	700
Proceeds from abl facility	3,021	2,189
Repayments of long-term indebtedness	6,272	3,380
Net cash used in financing activities	-896	-575
Net change in cash and cash equivalents	86	419
Cash and cash equivalents at beginning of period	37	-
Cash and cash equivalents at end of period	123	-

Unit: Million (M) dollars (except for numbers of shares and EPS)

Time Plot

Show the time plot by selecting a row from the table.

CYH: the cashflow